Spleen tyrosine kinase (Syk) as a therapeutic target in antibody-dependent transplant rejection

Project: Research

StatusFinished
Effective start/end date1/01/1431/12/16

Funding

  • National Health & Medical Research Council (NHMRC): AUD605,558.00